Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation

Nienke M. Stege, Rudolf A. de Boer, Catherine A. Makarewich, Peter van der Meer, Herman H.W. Silljé*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)
80 Downloads (Pure)

Abstract

The phospholamban (PLN) pathogenic gene variant, p.Arg14del (PLN-R14del), can lead to dilated and arrhythmogenic cardiomyopathy, resulting in heart failure. PLN-R14del cardiomyopathy has been conceptualized as a disease caused by sarco/endoplasmic reticulum calcium adenosine triphosphatase 2a (SERCA2a) superinhibition. However, recent studies raised controversy regarding the effect of PLN-R14del on SERCA activity and revealed a prominent role for abnormal PLN protein distribution and sarco/endoplasmic reticulum disorganization as underlying disease mechanism. Strategies targeting sarco/endoplasmic reticulum malformation may, therefore, prove more effective than SERCA activity modulation. This review reassesses the disease mechanisms of PLN-R14del cardiomyopathy and emphasizes the importance of dissecting the underlying molecular mechanisms to uncover targets for innovative treatments.

Original languageEnglish
Pages (from-to)1041-1052
Number of pages12
JournalJACC: Basic to Translational Science
Volume9
Issue number8
DOIs
Publication statusPublished - Aug-2024

Keywords

  • aggregation
  • cardiomyopathy
  • disease mechanism
  • p.Arg14del
  • phospholamban
  • sarcoplasmic reticulum
  • SERCA

Fingerprint

Dive into the research topics of 'Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation'. Together they form a unique fingerprint.

Cite this